Comment on “Polypharmacy and Kidney Function in Community-Dwelling Adults Age 60 Years and Older: A Prospective Observational Study”

Abstract

Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: A qualitative systematic review. Ann Pharmacother 2012;46:265e275. 8. van der Steeg WA, Holme I, Boekholdt SM, et al. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk: The IDEAL and EPIC-Norfolk studies. J Am Coll Cardiol 2008;51:634e642.